Net loss per share (Tables)

9 Months Ended

Sep. 30, 2019

Schedule of basic and diluted net loss attributable to ordinary shareholders

Basic and diluted net loss per share attributable to ordinary shareholders was calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2019		2018		2019		2018
Numerator:
Net loss attributable to ordinary shareholders	$	(9,482)	$	(7,692)	$	(26,202)	$	(15,205)
Denominator:
Weighted average ordinary shares outstanding, basic and diluted		17,900,978		433,795		8,734,943		417,223
Net loss per share attributable to ordinary shareholders, basic and diluted	$	(0.53)	$	(17.73)	$	(3.00)	$	(36.44)

Schedule of antidilutive securities excluded from computation of net loss per share attributable to ordinary shareholders


	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2019	2018	2019	2018
Convertible preferred shares (as converted to ordinary shares)	—	9,641,740	—	9,641,740
Warrants to subscribe for convertible preferred shares (as adjusted to reflect the impact of the share capital reorganization and issuance of bonus shares (Note 1))(1)(2)	114,320	1,347,953	114,320	1,347,953
Restricted ordinary shares	—	123,735	—	123,735
Options to purchase ordinary shares	2,637,275	971,079	2,637,275	971,079
	2,751,595	12,084,507	2,751,595	12,084,507

(1)

On March 7, 2019, the holders of the Series B1 warrants to subscribe for Series B1 Preferred Shares agreed that 50% of the warrants would be exercised in conjunction with the IPO and 50% of the warrants would expire.

At September 30, 2019, 80,000 warrants are outstanding which are exercisable into 114,320 ordinary shares (Note 6).